Benzinga - Thu, 08 Apr 2021 05:01:56 -0400
Benzinga - Wed, 07 Apr 2021 13:04:30 -0400
Benzinga - Wed, 07 Apr 2021 12:51:35 -0400
Benzinga - Wed, 07 Apr 2021 03:11:08 -0400
Benzinga - Tue, 06 Apr 2021 12:33:59 -0400
Benzinga - Thu, 01 Apr 2021 08:13:09 -0400
Benzinga - Fri, 26 Mar 2021 07:00:52 -0400
Benzinga - Thu, 25 Mar 2021 04:59:22 -0400
Benzinga - Wed, 24 Mar 2021 12:35:31 -0400
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-28
REV
Q4 2020Est.ActualSurprise
EPS-0.060
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EYESSecond Sight Medical-0.97%229.9M

Second Sight Medical Company Questions & Answers

Q

How do I buy Second Sight Medical (EYES) stock?

A

You can purchase shares of Second Sight Medical (NASDAQ: EYES) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Second Sight Medical's (EYES) main competitors?

A

Other companies in Second Sight Medical’s space includes: Venus Concept (NASDAQ:VERO), PAVmed (NASDAQ:PAVM) and Soliton (NASDAQ:SOLY).

Q

What is the target price for Second Sight Medical?

A

The latest price target for Second Sight Medical (NASDAQ: EYES) was reported by Dougherty & Co. on 2019-12-13. The analyst firm set a price target for 2.00 expecting EYES to fall to within 12 months (a possible -75.73% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Second Sight Medical (EYES) stock ?

A

The stock price for Second Sight Medical (NASDAQ: EYES) is $8.24 last updated Today at 8:00:02 PM.

Q

When is the next Second Sight Medical (EYES) dividend?

A

There are no upcoming dividends for Second Sight Medical.

Q

When is Second Sight Medical (NASDAQ:EYES) reporting earnings?

A
Second Sight Medical’s Q1 earnings are confirmed from now on June 28, 2021.
Q

When is the upcoming split for EYES?

A

There is no upcoming split for Second Sight Medical.